skip to main content
Hide All The Ads With a Yearly Membership Subscribe ▶

H.R. 2430 (115th): FDA Reauthorization Act of 2017

React to this bill with an emoji

(About Ads | Hide These Ads)

About the bill

Although health care is one of the most partisan political subjects, a new health care law was just signed with almost unanimous support. The FDA Reauthorization Act of 2017 aims to lower prescription drug prices, amid skyrocketing health insurance costs.

What the law does

The law is an amalgamation of provisions from at least eight different standalone healthcare-related bills which had been introduced earlier this year from both parties. Among its most notable provisions:

  • Reauthorizes so-called “user fees” to the Food and Drug Administration for five years. These fees are paid for by medical drug and device manufacturers with every new product application, and will account for $8 billion over the next five years, or about a quarter of the FDA’s total budget. President Trump actually wanted the FDA …

Sponsor and status

Photo of sponsor Greg Walden

Greg Walden

Sponsor. Representative for Oregon's 2nd congressional district. Republican.

Thumbnail of bill text
Read Text »
Last Updated: Aug 5, 2017
Length: 86 pages
Introduced
May 16, 2017
115th Congress (2017–2019)
Status

Enacted — Signed by the President on Aug 18, 2017

This bill was enacted after being signed by the President on August 18, 2017.

Law
Pub.L. 115-52
Cosponsors

3 Cosponsors (2 Democrats, 1 Republican)

Source
Congress.gov

Incorporated legislation

This bill incorporates provisions from:

S. 934: FDA Reauthorization Act of 2017

Ordered Reported on May 11, 2017. 63% incorporated. (compare text)

S. 1062: FDA Reporting Transparency and Accountability Act

Introduced on May 4, 2017. 29% incorporated. (compare text)

H.R. 1231: RACE for Children Act

Introduced on Feb 27, 2017. 61% incorporated. (compare text)

S. 456: RACE for Children Act

Introduced on Feb 27, 2017. 61% incorporated. (compare text)

S. 1069: Medical Device Safety Monitoring Act

Introduced on May 8, 2017. 66% incorporated. (compare text)

S. 1048: Enhanced Clinical Trial Design Act of 2017

Introduced on May 4, 2017. 76% incorporated. (compare text)

H.R. 1652: Over-the-Counter Hearing Aid Act of 2017

Introduced on Mar 21, 2017. 93% incorporated. (compare text)

S. 670: Over-the-Counter Hearing Aid Act of 2017

Introduced on Mar 21, 2017. 93% incorporated. (compare text)

(About Ads | Hide These Ads)

History

May 16, 2017
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

Read Text »

May 18, 2017
 
Considered by Health

A committee held a hearing or business meeting about the bill.

Jun 7, 2017
 
Ordered Reported

A committee has voted to issue a report to the full chamber recommending that the bill be considered further. Only about 1 in 4 bills are reported out of committee.

Read Updated Text » See Changes »

Jul 11, 2017
 
Reported by House Committee on Energy and Commerce

A committee issued a report on the bill, which often provides helpful explanatory background on the issue addressed by the bill and the bill's intentions.

Read Report »

Jul 12, 2017
 
Passed House (Senate next)

The bill was passed in a vote in the House. It goes to the Senate next. The vote was by voice vote so no record of individual votes was made.

Read Updated Text » See Changes »

Aug 3, 2017
 
Passed Senate

The bill was passed by both chambers in identical form. It goes to the President next who may sign or veto the bill.

thumbnail image of vote View Vote » Read Updated Text » See Changes »

Aug 18, 2017
 
Enacted — Signed by the President

The President signed the bill and it became law.

H.R. 2430 (115th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

Bills numbers restart every two years. That means there are other bills with the number H.R. 2430. This is the one from the 115th Congress.

This bill was introduced in the 115th Congress, which met from Jan 3, 2017 to Jan 3, 2019. Legislation not passed by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 2430 — 115th Congress: FDA Reauthorization Act of 2017.” www.GovTrack.us. 2017. May 31, 2023 <https://www.govtrack.us/congress/bills/115/hr2430>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.